Alyeska Investment Group
BOLD

Alyeska Investment Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Alyeska Investment Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-171,219
Closed -$10.2M – 537
2019
Q4 		$10.2M Buy
+171,219
New +$6.43M 0.14% 167
2017
Q2 		– Sell
-100,138
Closed -$1.71M – 588
2017
Q1 		$1.71M Buy
100,138
+243
+0.2% +$3.93K 0.01% 408
2016
Q4 		$1.82M Sell
99,895
-21,840
-18% -$377K 0.02% 394
2016
Q3 		$2.17M Buy
+121,735
New +$1.85M 0.02% 382

Alyeska Investment Group's BOLD Position: Q1 2020 in Review

Alyeska Investment Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 171,219 shares — an estimated $10.2M sold.

Alyeska Investment Group first reported a position in BOLD in Q3 2016 and held it in 4 quarters. The position peaked at $10.2M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Alyeska Investment Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 171,219 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $10.2M.
  • Alyeska Investment Group first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 4 quarters.
  • Alyeska Investment Group's Audentes Therapeutics, Inc position peaked at $10.2M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Alyeska Investment Group's 13F filing for Q1 2020, filed 15 May 2020.